The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV

Redox Biology

Volumn 1, Issue 1, 2013, Pages 532-541

  Tao, Shasha ^a   Justiniano, Rebecca ^a,b   Zhang, Donna D ^a,b   Wondrak, Georg T ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Dihydrotanshinone; Nrf2; Skin photoprotection; Solar simulated ultraviolet light; Tanshinone I

Indexed keywords

ANTIOXIDANT; CRYPTOTANSHINONE; DIHYDROTANSHINONE; DNA; GLUTATHIONE; LUCIFERASE; PHENANTHRENEQUINONE; PROCASPASE 3; RIBOFLAVIN; TANSHINONE I; TANSHINONE IIA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ABIETANE DERIVATIVE; NFE2L2 PROTEIN, HUMAN; SUNSCREEN; TANSHINONE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL DEATH; CELL PROTECTION; CYTOPLASM; DNA REPAIR; DRUG EFFICACY; DRUG STRUCTURE; ELECTROPHILICITY; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; OXIDATION REDUCTION STATE; PHOTOAGING; PRIORITY JOURNAL; RADIATION EXPOSURE; SALVIA MILTIORRHIZA; SKIN CELL; SKIN PROTECTION; TRANSCRIPTION INITIATION; UBIQUITINATION; ULTRAVIOLET RADIATION; UPREGULATION; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RADIATION RESPONSE;

CELL LINE; DITERPENES, ABIETANE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; NF-E2-RELATED FACTOR 2; SUNSCREENING AGENTS; UBIQUITINATION; ULTRAVIOLET RAYS;

EID: 84888049417     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.10.004     Document Type: Article

References (59)

1. Wakabayashi N., Slocum S.L., Skoko J.J., Shin S., Kensler T.W. When NRF2 talks, who's listening?. Antioxid. Redox Signal. 2010, 13:1649-1663.
2. Jiang T., Huang Z., Chan J.Y., Zhang D.D. Nrf2 protects against As(III)-induced damage in mouse liver and bladder. Toxicol. Appl. Pharmacol. 2009, 240:8-14.
3. Suzuki T., Motohashi H., Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 2013, 34:340-346.
4. Hu R., Saw C.L., Yu R., Kong A.N. Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory. Antioxid. Redox Signal. 2010, 13:1679-1698.
5. Schafer M., Dutsch S., auf dem Keller U., Navid F., Schwarz A., Johnson D.A., Johnson J.A., Werner S. Nrf2 establishes a glutathione-mediated gradient of UVB cytoprotection in the epidermis. Genes Dev. 2010, 24:1045-1058.
6. Saw C.L., Huang M.T., Liu Y., Khor T.O., Conney A.H., Kong A.N. Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane. Mol. Carcinog. 2011, 50:479-486.
7. Kim S.B., Pandita R.K., Eskiocak U., Ly P., Kaisani A., Kumar R., Cornelius C., Wright W.E., Pandita T.K., Shay J.W. Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2949-2955.
8. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 2013, 53:401-426.
9. Du Y., Villeneuve N.F., Wang X.J., Sun Z., Chen W., Li J., Lou H., Wong P.K., Zhang D.D. Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ. Health Perspect. 2008, 116:1154-1161.
10. Lau A., Whitman S.A., Jaramillo M.C., Zhang D.D. Arsenic-mediated activation of the Nrf2-Keap1 antioxidant pathway. J. Biochem. Mol. Toxicol. 2013, 27:99-105.
11. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 2006, 38:1-21.
12. Kensler T.W., Wakabayashi N. Nrf2: friend or foe for chemoprevention?. Carcinogenesis 2010, 31:90-99.
13. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 2004, 24:10941-10953.
14. Dinkova-Kostova A.T., Holtzclaw W.D., Kensler T.W. The role of Keap1 in cellular protective responses. Chem. Res. Toxicol. 2005, 18:1779-1791.
15. Hayes J.D., McMahon M., Chowdhry S., Dinkova-Kostova A.T. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid. Redox Signal. 2010, 13:1713-1748.
16. Adams J.D., Wang R., Yang J., Lien E.J. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin. Med. 2006, 1:3.
17. Wang X., Morris-Natschke S.L., Lee K.H. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med. Res. Rev. 2007, 27:133-148.
18. Gao S., Liu Z., Li H., Little P.J., Liu P., Xu S. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis 2012, 220:3-10.
19. Tao S., Zheng Y., Lau A., Jaramillo M.C., Chau B.T., Lantz R.C., Wong P.K., Wondrak G.T., Zhang D.D. Tanshinone I Activates the Nrf2-dependent antioxidant response and protects against As(III)-induced lung inflammation in vitro and in vivo. Antioxid. Redox Signal. 2013, 19:1647-1661.
20. Kullavanijaya P., Lim H.W. Photoprotection. J. Am. Acad. Dermatol. 2005, 52:937-958. (quiz 959-962).
21. Lautenschlager S., Wulf H.C., Pittelkow M.R. Photoprotection. Lancet 2007, 370:528-537.
22. Lamore S.D., Qiao S., Horn D., Wondrak G.T. Proteomic identification of cathepsin B and nucleophosmin as novel UVA-targets in human skin fibroblasts. Photochem. Photobiol. 2010, 86:1307-1317.
23. Lamore S.D., Azimian S., Horn D., Anglin B.L., Uchida K., Cabello C.M, Wondrak G.T. The malondialdehyde-derived fluorophore DHP-lysine is a potent sensitizer of UVA-induced photooxidative stress in human skin cells. J. Photochem. Photobiol. B 2010, 101:251-264.
24. Svobodova A., Vostalova J. Solar radiation induced skin damage: review of protective and preventive options. Int. J. Radiat. Biol. 2010, 86:999-1030.
25. Fourtanier A., Moyal D., Seite S. UVA filters in sun-protection products: regulatory and biological aspects. Photochem. Photobiol. Sci. 2012, 11:81-89.
26. Wondrak G.T., Jacobson M.K., Jacobson E.L. Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem. Photobiol. Sci. 2006, 5:215-237.
27. Hirota A., Kawachi Y., Itoh K., Nakamura Y., Xu X., Banno T., Takahashi T., Yamamoto M., Otsuka F. Ultraviolet A irradiation induces NF-E2-related factor 2 activation in dermal fibroblasts: protective role in UVA-induced apoptosis. J. Invest. Dermatol. 2005, 124:825-832.
28. Dinkova-Kostova A.T., Jenkins S.N., Fahey J.W., Ye L., Wehage S.L., Liby K.T., Stephenson K.K., Wade K.L., Talalay P. Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. Cancer Lett. 2006, 240:243-252.
29. Benedict A.L., Knatko E.V., Dinkova-Kostova A.T. The indirect antioxidant sulforaphane protects against thiopurine-mediated photooxidative stress. Carcinogenesis 2012, 33:2457-2466.
30. Gruber F., Mayer H., Lengauer B., Mlitz V., Sanders J.M., Kadl A., Bilban M., de Martin R., Wagner O., Kensler T.W., Yamamoto M., Leitinger N., Tschachler E. NF-E2-related factor 2 regulates the stress response to UVA-1-oxidized phospholipids in skin cells. FASEB J. 2010, 24:39-48.
31. Tian F.F., Zhang F.F., Lai X.D., Wang L.J., Yang L., Wang X., Singh G., Zhong J.L. Nrf2-mediated protection against UVA radiation in human skin keratinocytes. Biosci. Trends 2011, 5:23-29.
32. Hirota A., Kawachi Y., Yamamoto M., Koga T., Hamada K., Otsuka F. Acceleration of UVB-induced photoageing in nrf2 gene-deficient mice. Exp. Dermatol. 2011, 20:664-668.
33. Kalra S., Knatko E.V., Zhang Y., Honda T., Yamamoto M., Dinkova-Kostova A.T. Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone): implications for protection against UV radiation during thiopurine therapy. Cancer Prev. Res. Philadelphia 2012, 5:973-981.
34. Kawachi Y., Xu X., Taguchi S., Sakurai H., Nakamura Y., Ishii Y., Fujisawa Y., Furuta J., Takahashi T., Itoh K., Yamamoto M., Yamazaki F., Otsuka F. Attenuation of UVB-induced sunburn reaction and oxidative DNA damage with no alterations in UVB-induced skin carcinogenesis in Nrf2 gene-deficient mice. J. Invest. Dermatol. 2008, 128:1773-1779.
35. Lieder F., Reisen F., Geppert T., Sollberger G., Beer H.D., auf dem Keller U., Schafer M., Detmar M., Schneider G., Werner S. Identification of UV-protective activators of nuclear factor erythroid-derived 2-related factor 2 (Nrf2) by combining a chemical library screen with computer-based virtual screening. J. Biol. Chem. 2012, 287:33001-33013.
36. Lamore S.D., Wondrak G.T. UVA causes dual inactivation of cathepsin B and L underlying lysosomal dysfunction in human dermal fibroblasts. J. Photochem. Photobiol. B 2013, 123:1-12.
37. Wang X.J., Sun Z., Chen W., Li Y., Villeneuve N.F., Zhang D.D. Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. Toxicol. Appl. Pharmacol. 2008, 230:383-389.
38. Sun Z., Zhang S., Chan J.Y., Zhang D.D. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell. Biol. 2007, 27:6334-6349.
39. Lamore S.D., Wondrak G.T. Zinc pyrithione impairs zinc homeostasis and upregulates stress response gene expression in reconstructed human epidermis. Biometals 2011, 24:875-890.
40. Zhang D.D., Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol 2003, 23:8137-8151.
41. Sato K., Taguchi H., Maeda T., Minami H., Asada Y., Watanabe Y., Yoshikawa K. The primary cytotoxicity in ultraviolet-a-irradiated riboflavin solution is derived from hydrogen peroxide. J. Invest. Dermatol. 1995, 105:608-612.
42. Wondrak G.T., Roberts M.J., Jacobson M.K., Jacobson E.L. 3-Hydroxypyridine chromophores are endogenous sensitizers of photooxidative stress in human skin cells. J. Biol. Chem. 2004, 279:30009-30020.
43. Van Laethem A., Claerhout S., Garmyn M., Agostinis P. The sunburn cell: regulation of death and survival of the keratinocyte. Int. J. Biochem. Cell. Biol. 2005, 37:1547-1553.
44. Bernerd F., Asselineau D. An organotypic model of skin to study photodamage and photoprotection in vitro. J. Am. Acad. Dermatol. 2008, 58:S155-159.
45. Marrot L., Meunier J.R. Skin DNA photodamage and its biological consequences. J. Am. Acad. Dermatol. 2008, 58:S139-148.
46. Gasparro F.P. Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy. Environ. Health Perspect. 2000, 108(Suppl. 1):71-78.
47. Wondrak G.T. Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage. Curr. Opin. Invest. Drugs 2007, 8:390-400.
48. Matsui M.S., Hsia A., Miller J.D., Hanneman K., Scull H., Cooper K.D., Baron E. Non-sunscreen photoprotection: antioxidants add value to a sunscreen. J. Invest. Dermatol. Symp. Proc. 2009, 14:56-59.
49. Dinkova-Kostova A.T. Phytochemicals as protectors against ultraviolet radiation: versatility of effects and mechanisms. Planta Med. 2008, 74:1548-1559.
50. Baliga M.S., Katiyar S.K. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. Photobiol. Sci. 2006, 5:243-253.
51. Afaq F., Mukhtar H. Botanical antioxidants in the prevention of photocarcinogenesis and photoaging. Exp. Dermatol. 2006, 15:678-684.
52. Nichols J.A., Katiyar S.K. Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch. Dermatol. Res. 2010, 302:71-83.
53. Wondrak G.T., Cabello C.M., Villeneuve N.F., Zhang S., Ley S., Li Y., Sun Z., Zhang D.D. Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress. Free Radic. Biol. Med. 2008, 45:385-395.
54. Hseu Y.C., Chou C.W., Senthil Kumar K.J., Fu K.T., Wang H.M., Hsu L.S., Kuo Y.H., Wu C.R., Chen S.C., Yang H.L. Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes. Food Chem. Toxicol. 2012, 50:1245-1255.
55. Dickinson S.E., Melton T.F., Olson E.R., Zhang J., Saboda K., Bowden G.T. Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer. Cancer Res. 2009, 69:7103-7110.
56. Kim Y.R., Oh J.E., Kim M.S., Kang M.R., Park S.W., Han J.Y., Eom H.S., Yoo N.J., Lee S.H. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J. Pathol. 2010, 220:446-451.
57. Wang X.J., Sun Z., Villeneuve N.F., Zhang S., Zhao F., Li Y., Chen W., Yi X., Zheng W., Wondrak G.T., Wong P.K., Zhang D.D. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 2008, 29:1235-1243.
58. Zhang D.D. The Nrf2-Keap1-ARE signaling pathway: the regulation and dual function of Nrf2 in cancer. Antioxid. Redox Signal. 2010, 13:1623-1626.
59. Schafer M., Farwanah H., Willrodt A.H., Huebner A.J., Sandhoff K., Roop D., Hohl D., Bloch W., Werner S. Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol. Med. 2012, 4:364-379.